Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
about
Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection.Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus DiseaseStaphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.Rapid Detection of Bacteria from Blood with Surface-Enhanced Raman Spectroscopy.The Staphylococcus aureus cell wall-anchored protein clumping factor A is an important T cell antigen.Invasive disease caused simultaneously by dual serotypes of Streptococcus pneumoniae.
P2860
Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preclinical Efficacy of Clumpi ...... aphylococcus aureus Infection.
@ast
Preclinical Efficacy of Clumpi ...... aphylococcus aureus Infection.
@en
type
label
Preclinical Efficacy of Clumpi ...... aphylococcus aureus Infection.
@ast
Preclinical Efficacy of Clumpi ...... aphylococcus aureus Infection.
@en
prefLabel
Preclinical Efficacy of Clumpi ...... aphylococcus aureus Infection.
@ast
Preclinical Efficacy of Clumpi ...... aphylococcus aureus Infection.
@en
P2093
P2860
P356
P1433
P1476
Preclinical Efficacy of Clumpi ...... taphylococcus aureus Infection
@en
P2093
Christopher D Thompson
Saeyoung Park
Wan Beom Park
Xiaogang Wang
P2860
P304
P356
10.1128/MBIO.02232-15
P50
P577
2016-02-02T00:00:00Z